查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820269

分叉病变市场报告（按类型（单支架、双支架）、应用（冠状血管、週边血管）和地区划分）2025-2033

Bifurcation Lesions Market Report by Types (One-Stent, Two-Stent), Application (Coronary Vascular, Peripheral Vascular), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2024年全球分叉病变市场规模达25亿美元。展望未来， IMARC Group预计到2033年市场规模将达到38亿美元，2025-2033年期间的成长率（CAGR）为4.4%。

分叉病变是指冠状动脉重要侧支（SB）起源附近的狭窄。由于血流湍急和高切应力，分叉病变容易形成动脉粥状硬化斑块。分叉病变的治疗手段包括分析、手术时间、X 光照射和长期追踪等。此外，三维 (3D) 血管摄影和多层 CT 可用于测量分叉角度。随着设备、影像技术、辅助药物治疗和血管通路的进步，全球复杂分叉病变的治疗正变得越来越可能。

分叉病变市场趋势：

冠状动脉疾病 (CAD) 发生率的显着上升增加了分叉病变的风险。这是推动市场成长的关键因素之一。此外，创新设备的批准、保险覆盖范围的扩大以及成像方式的改进也加强了市场的成长。此外，老年人口的增加（他们更容易患上疾病）以及各国政府为报销而采取的支持性措施正在支持市场的成长。日益增长的医疗旅游业、对微创 (MI) 手术日益增长的需求以及不断改善的医疗保健基础设施是促进市场成长的其他一些因素。除此之外，正在进行的新型治疗技术的研究也正在推动市场的发展。例如，研究人员正在研究 Szabo 双支架技术对复杂分叉病变的有效性，这些病变具有较高的危及生命的风险，甚至会导致 SB 闭塞致命。此外，随着熟练的医疗保健专业人员数量的增加，对支架和球囊进行广泛的临床试验，预计将降低与分叉病变治疗相关的风险并对市场产生积极影响。

本报告回答的关键问题

  • 2024年全球分叉病变市场规模？ 2025-2033年全球分叉病变市场的预期成长率是多少？
  • COVID-19 对全球分叉病变市场有何影响？
  • 推动全球分叉病变市场发展的关键因素有哪些？
  • 根据应用，全球分叉病变市场是如何分布的？
  • 全球分叉病变市场的主要区域有哪些？
  • 全球分叉病变市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球分叉病变市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 单支架
  • 双支架

第七章：市场区隔：依应用

  • 冠状血管
  • 週边血管

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boston Scientific Corporation
    • Cardinal Health
    • Medtronic plc
    • Spectranetics (Koninklijke Philips NV)
    • Terumo Corporation
Product Code: SR112025A4003

The global bifurcation lesions market size reached USD 2.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033.

A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.

Bifurcation Lesions Market Trends:

A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.

Key Market Segmentation:

Breakup by Types:

  • One-Stent
  • Two-Stent

Breakup by Application:

  • Coronary Vascular
  • Peripheral Vascular

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.

Key Questions Answered in This Report

  • 1.What was the size of the global bifurcation lesions market in 2024?
  • 2.What is the expected growth rate of the global bifurcation lesions market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global bifurcation lesions market?
  • 4.What are the key factors driving the global bifurcation lesions market?
  • 5.What is the breakup of the global bifurcation lesions market based on the application?
  • 6.What are the key regions in the global bifurcation lesions market?
  • 7.Who are the key players/companies in the global bifurcation lesions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bifurcation Lesions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Types

  • 6.1 One-Stent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Two-Stent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Peripheral Vascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Boston Scientific Corporation
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Cardinal Health
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Medtronic plc
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Spectranetics (Koninklijke Philips N.V.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Terumo Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bifurcation Lesions Market: Major Drivers and Challenges
  • Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2024
  • Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2024
  • Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
  • Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
  • Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bifurcation Lesions Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Bifurcation Lesions Market Forecast: Breakup by Types (in Million USD), 2025-2033
  • Table 3: Global: Bifurcation Lesions Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Bifurcation Lesions Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Bifurcation Lesions Market: Competitive Structure
  • Table 6: Global: Bifurcation Lesions Market: Key Players